8-K Announcements
6Material company update
Jun 11, 2026·SEC
Material company update
Jun 11, 2026·SEC
Material company update
Jun 5, 2026·SEC
VSee Health, Inc.(VSEEW)Earnings, Financials & Key Ratios
VSEEW•NASDAQ
$0.04
Price updated Jun 30, 2026
AboutVSee Health, Inc. provides telehealth care solutions. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. Its telehealth platform provides a set of building blocks to solve needs of clients. VSee Health, Inc. is headquartered in Newton, Massachusetts.Show more
- Revenue$15M+40.3%
- EBITDA-$7M+88.6%
- Net Income-$15M+74.5%
- EPS (Diluted)-0.73+87.1%
- Gross Margin50.32%-26.9%
- EBITDA Margin-47.4%+91.9%
- Operating Margin-65.55%+89.0%
- Net Margin-100.65%+81.8%
- ROE-541.52%
VSEEW Price & Volume
VSee Health, Inc. (VSEEW) stock price & volume — 10-year historical chart
Loading chart...
Persistent Operational Losses Threaten Long-Term Solvency
Investment Thesis • Updated 2026Q1
VerdictNegative: The company's inability to achieve economies of scale
Growth:Decelerating
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Insufficient liquidity for operations
Key Thesis Takeaways
- VSee Health faces a challenging outlook as its revenue growth has shifted from triple-digit expansion to a 4.9% contraction in 2026Q1, signaling that its hospital deployment strategy is struggling to scale.
- The company's reliance on intangible assets, with $4.9M in goodwill representing a significant portion of its $19.0M total asset base, combined with a persistent net margin of -82.3%, suggests a precarious financial position.
- Investors should monitor the company's ability to manage its $2.1M debt load against a dwindling cash balance of only $1.3M, which may necessitate further dilutive capital raises.
Verdict Logic
evidenced by a -57.7% operating margin in 2026Q1, combined with a precarious $1.3M cash position, presents an unsustainable risk profile for long-term investors.
VSEEW Growth Metrics
VSee Health, Inc. (VSEEW) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years16.52%
3 Years31.85%
TTM18.05%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM78.34%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM86.87%
Return on Capital
10 Years-1306.51%
5 Years-1649.6%
3 Years-3297.98%
Last Year-268.03%
VSEEW Recent Earnings
VSee Health, Inc. (VSEEW) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (40%)●Beat Revenue 1/12 qtrs (20%)
Q2 2026Latest
May 15, 2026Metric
Actual
Est
EPS
$0.05+54.5%
$0.11
Rev
$3M-34.2%
$5M
Q2 2026
Mar 31, 2026Metric
Actual
Est
EPS
$0.31-287.5%
$0.08
Rev
$4M-10.8%
$4M
Q4 2025
Nov 19, 2025Metric
Actual
Est
EPS
$0.02+78.1%
$0.08
Rev
$4M-5.2%
$4M
Q4 2025
Oct 15, 2025Metric
Actual
Est
EPS
$0.16-32.6%
$0.12
Rev
$3M-13.1%
$4M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 15, 2026 | $0.05vs $0.11+54.5% | $3Mvs $5M-34.2% |
| Q2 2026 | Mar 31, 2026 | $0.31vs $0.08-287.5% | $4Mvs $4M-10.8% |
| Q4 2025 | Nov 19, 2025 | $0.02vs $0.08+78.1% | $4Mvs $4M-5.2% |
| Q4 2025 | Oct 15, 2025 | $0.16vs $0.12-32.6% | $3Mvs $4M-13.1% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for VSee Health, Inc. (VSEEW)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.04 | $991.81K | -0.05 | 40.27% | -100.65% | -541.52% | — | |
| $8.69 | $1.57B | -7.62 | -1.54% | -6.81% | -12.37% | — | |
| $9.30 | $155.39M | -1.56 | -1.98% | -48.16% | -33.48% | — | |
| $5.43 | $101.89M | 20.11 | 18.78% | 6.37% | 5.47% | — | |
| $5.20 | $871.07M | 130.00 | 22% | 0.49% | 1.03% | — | |
| $33.39 | $7.33B | 65.47 | 59% | -0.56% | -2.48% | — |
Compare VSEEW vs Peers
VSee Health, Inc. (VSEEW) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
VSEEW SEC Filings & Documents
VSee Health, Inc. (VSEEW) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when VSEEW posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
VSEEW Frequently Asked Questions
VSee Health, Inc. (VSEEW) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is VSee Health, Inc.'s revenue?
VSee Health, Inc. (VSEEW) reported $14.5M in revenue for fiscal year 2025. This represents a 112% increase from $6.8M in 2020.
How fast is VSee Health, Inc. growing?
VSee Health, Inc. (VSEEW) grew revenue by 40.3% over the past year. This is strong growth.
Is VSEEW profitable?
VSee Health, Inc. (VSEEW) reported a net loss of $13.4M for fiscal year 2025.
Dividend & Returns
What is VSEEW's return on equity?
VSee Health, Inc. (VSEEW) has a return on equity (ROE) of -541.5%. Negative ROE indicates the company is unprofitable.
What is VSee Health, Inc.'s free cash flow?
VSee Health, Inc. (VSEEW) had negative free cash flow of $5.5M in fiscal year 2025, likely due to heavy capital investments.